open access

Vol 18, No 3 (2011)
Original articles
Published online: 2011-06-09
Get Citation

Gender-related benefit of transport to primary angioplasty: Is it equal?

Marcin Sadowski, Agnieszka Janion-Sadowska, Mariusz Gąsior, Marek Gierlotka, Marianna Janion, Lech Poloński
Cardiol J 2011;18(3):254-260.

open access

Vol 18, No 3 (2011)
Original articles
Published online: 2011-06-09

Abstract


Background. Infarct size is correlated with duration of coronary artery occlusion. Evidence suggests that transport for primary angioplasty improves outcomes, but there is no agreement regarding differences in prognosis between men and women. We compared outcomes in men and women with ST-segment elevation myocardial infarction (STEMI) transferred from another hospital against those who had been transported directly to an invasive treatment center.
Methods. Data was collected between June 2005 and May 2006 from a registry of 26,035 patients with STEMI and in whom primary angioplasty had been performed.
Results. A total of 10,708 patients underwent primary angioplasty. Of these, 3,359 men and 1,469 women were transported directly, while 4,135 men and 1,745 women were transferred from another site. In-hospital mortality and at one month, six months and 12 months after hospital discharge was significantly higher in women than in men. The prognosis of women transported directly was similar to that of women transferred from another site. However, there was a tendency, albeit insignificant, towards higher mortality at six and 12 months in women transported from another hospital.
Conclusions. To reduce mortality in STEMI, an immediate reperfusion must not be delayed. This conclusion is valid particularly for women who are at greater risk of death. (Cardiol J 2011; 18, 3: 254–260)

Abstract


Background. Infarct size is correlated with duration of coronary artery occlusion. Evidence suggests that transport for primary angioplasty improves outcomes, but there is no agreement regarding differences in prognosis between men and women. We compared outcomes in men and women with ST-segment elevation myocardial infarction (STEMI) transferred from another hospital against those who had been transported directly to an invasive treatment center.
Methods. Data was collected between June 2005 and May 2006 from a registry of 26,035 patients with STEMI and in whom primary angioplasty had been performed.
Results. A total of 10,708 patients underwent primary angioplasty. Of these, 3,359 men and 1,469 women were transported directly, while 4,135 men and 1,745 women were transferred from another site. In-hospital mortality and at one month, six months and 12 months after hospital discharge was significantly higher in women than in men. The prognosis of women transported directly was similar to that of women transferred from another site. However, there was a tendency, albeit insignificant, towards higher mortality at six and 12 months in women transported from another hospital.
Conclusions. To reduce mortality in STEMI, an immediate reperfusion must not be delayed. This conclusion is valid particularly for women who are at greater risk of death. (Cardiol J 2011; 18, 3: 254–260)
Get Citation

Keywords

ST-segment elevation myocardial infarction; time to reperfusion; transfer; gender

About this article
Title

Gender-related benefit of transport to primary angioplasty: Is it equal?

Journal

Cardiology Journal

Issue

Vol 18, No 3 (2011)

Pages

254-260

Published online

2011-06-09

Bibliographic record

Cardiol J 2011;18(3):254-260.

Keywords

ST-segment elevation myocardial infarction
time to reperfusion
transfer
gender

Authors

Marcin Sadowski
Agnieszka Janion-Sadowska
Mariusz Gąsior
Marek Gierlotka
Marianna Janion
Lech Poloński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl